Literature DB >> 1918398

Blood component treatment: a retrospective audit in five major London hospitals.

A Thomson1, M Contreras, S Knowles.   

Abstract

A retrospective audit of 200 transfusion episodes involving the use of platelets or fresh frozen plasma (FFP) was performed in five hospitals in London. It examined the currently used practices of transfusion and assessed the appropriateness of blood component treatment. It was necessary to search for an excess of case notes to provide a sufficient number of patients for review. In 61.5% of cases the reason for using the components was not stated. Inadequate documentation of the use of blood components occurred in 66% of cases. An accepted clinical indication for the use of components was evident in only 36% of the total; inappropriate use of FFP was particularly apparent. It is concluded that many aspects of transfusion practice need to be improved.

Entities:  

Mesh:

Year:  1991        PMID: 1918398      PMCID: PMC496718          DOI: 10.1136/jcp.44.9.734

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  THE PROPHYLACTIC USE OF FRESH FROZEN PLASMA AFTER EXTRACORPOREAL CIRCULATION.

Authors:  A S TRIMBLE; J J OSBORN; W J KERTH; F GERBODE
Journal:  J Thorac Cardiovasc Surg       Date:  1964-08       Impact factor: 5.209

2.  Prospective-concurrent audits and medical consultation for platelet transfusions.

Authors:  M B Simpson
Journal:  Transfusion       Date:  1987 Mar-Apr       Impact factor: 3.157

3.  Modification of fresh-frozen plasma transfusion practices through educational intervention.

Authors:  R E Barnette; D J Fish; R S Eisenstaedt
Journal:  Transfusion       Date:  1990 Mar-Apr       Impact factor: 3.157

4.  An audit of blood component therapy in a Canadian general teaching hospital.

Authors:  W F Brien; R J Butler; M J Inwood
Journal:  CMAJ       Date:  1989-04-01       Impact factor: 8.262

5.  Bleeding after cardiopulmonary bypass.

Authors:  L A Harker
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

Review 6.  Transfusion of plasma components.

Authors:  A H Braunstein; H A Oberman
Journal:  Transfusion       Date:  1984 Jul-Aug       Impact factor: 3.157

7.  Transfusion pattern of fresh frozen plasma in a medical school hospital.

Authors:  B S Shaikh; D Wagar; P M Lau; E W Campbell
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

8.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release.

Authors:  L A Harker; T W Malpass; H E Branson; E A Hessel; S J Slichter
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

9.  Collection and transfusion of blood in the United States, 1982-1988.

Authors:  D M Surgenor; E L Wallace; S H Hao; R H Chapman
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

10.  Why is fresh-frozen plasma transfused?

Authors:  A J Snyder; J L Gottschall; J E Menitove
Journal:  Transfusion       Date:  1986 Jan-Feb       Impact factor: 3.157

  10 in total
  6 in total

1.  Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines.

Authors:  Cynthia Luk; Kathleen M Eckert; Robert M Barr; Ian H Chin-Yee
Journal:  CMAJ       Date:  2002-06-11       Impact factor: 8.262

2.  Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT).

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2007-04       Impact factor: 3.443

Review 3.  Blood bank audit.

Authors:  P H Pinkerton
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  Avoiding the misuse of fresh frozen plasma.

Authors:  H Cohen
Journal:  BMJ       Date:  1993-08-14

5.  Unfurling the rationale use of platelet transfusion in dengue Fever.

Authors:  P Pallavi; C K Ganesh; K Jayashree; G V Manjunath
Journal:  Indian J Hematol Blood Transfus       Date:  2011-04-11       Impact factor: 0.900

6.  An audit of platelet transfusion indications in acute leukaemia patients: six-year experience at an Academic Centre.

Authors:  José C Jaime-Pérez; Gerardo García-Salas; Grecia A Turrubiates-Hernández; Dalila M Alvarado-Navarro; Luis J Marfil-Rivera; David Gómez-Almaguer
Journal:  Blood Transfus       Date:  2020-11-03       Impact factor: 3.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.